These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 15642987
21. Immunoassay of modified forms of human low density lipoprotein in isolated circulating immune complexes. Virella G, Colglazier J, Chassereau C, Hunt KJ, Baker NL, Lopes-Virella MF. J Immunoassay Immunochem; 2013; 34(1):61-74. PubMed ID: 23323982 [Abstract] [Full Text] [Related]
22. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Boyd HC, Gown AM, Wolfbauer G, Chait A. Am J Pathol; 1989 Nov; 135(5):815-25. PubMed ID: 2683796 [Abstract] [Full Text] [Related]
23. OxPL/apoB, lipoprotein(a) and OxLDL biomarkers and cardiovascular disease in chronic hemodialysis patients. Bossola M, Tazza L, Luciani G, Tortorelli A, Tsimikas S. J Nephrol; 2011 Nov; 24(5):581-8. PubMed ID: 21404224 [Abstract] [Full Text] [Related]
25. Immunological detection of low-density lipoproteins modified by malondialdehyde in vitro or in vivo. Salmon S, Maziere C, Theron L, Beucler I, Ayrault-Jarrier M, Goldstein S, Polonovski J. Biochim Biophys Acta; 1987 Aug 15; 920(3):215-20. PubMed ID: 3111542 [Abstract] [Full Text] [Related]
26. Distribution of immunoreactive malondialdehyde-modified low-density lipoprotein in human serum. Kotani K, Maekawa M, Kanno T, Kondo A, Toda N, Manabe M. Biochim Biophys Acta; 1994 Nov 17; 1215(1-2):121-5. PubMed ID: 7947993 [Abstract] [Full Text] [Related]
27. Detection of IgG-bound lipoprotein(a) immune complexes in patients with coronary heart disease. Wang J, Qiang H, Zhang C, Liu X, Chen D, Wang S. Clin Chim Acta; 2003 Jan 17; 327(1-2):115-22. PubMed ID: 12482626 [Abstract] [Full Text] [Related]
29. Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albumin. Sakata N, Moh A, Takebayashi S. Heart Vessels; 2002 Nov 17; 17(1):22-9. PubMed ID: 12434198 [Abstract] [Full Text] [Related]
33. The preparation of copper-oxidized LDL for the measurement of oxidized LDL antibodies by EIA. Lopes-Virella MF, Koskinen S, Mironova M, Horne D, Klein R, Chassereau C, Enockson C, Virella G. Atherosclerosis; 2000 Sep 17; 152(1):107-15. PubMed ID: 10996345 [Abstract] [Full Text] [Related]
37. Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study. Mayr M, Kiechl S, Tsimikas S, Miller E, Sheldon J, Willeit J, Witztum JL, Xu Q. J Am Coll Cardiol; 2006 Jun 20; 47(12):2436-43. PubMed ID: 16781371 [Abstract] [Full Text] [Related]
38. Anti-modified LDL antibodies and LDL-containing immune complexes in IDDM patients and healthy controls. Mironova M, Virella G, Virella-Lowell I, Lopes-Virella MF. Clin Immunol Immunopathol; 1997 Oct 20; 85(1):73-82. PubMed ID: 9325072 [Abstract] [Full Text] [Related]
39. Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins. Radulescu L, Stancu C, Antohe F. Med Sci Monit; 2004 Jul 20; 10(7):BR207-14. PubMed ID: 15232494 [Abstract] [Full Text] [Related]